4-Pyridinecarboxylic acid, 2-(1-methylethyl)hydrazide, phosphate (1:1)


Chemical Name: 4-Pyridinecarboxylic acid, 2-(1-methylethyl)hydrazide, phosphate (1:1)
CAS Number: 305-33-9
Product Number: AG0030DU(AGN-PC-0JK908)
Synonyms:
MDL No:
Molecular Formula: C9H16N3O5P
Molecular Weight: 277.2142

Identification/Properties


Properties
MP:
181 °C
BP:
265.9°C at 760 mmHg
Storage:
Inert atmosphere;2-8℃;
Form:
Solid
Computed Properties
Molecular Weight:
277.217g/mol
Hydrogen Bond Donor Count:
5
Hydrogen Bond Acceptor Count:
7
Rotatable Bond Count:
3
Exact Mass:
277.083g/mol
Monoisotopic Mass:
277.083g/mol
Topological Polar Surface Area:
132A^2
Heavy Atom Count:
18
Formal Charge:
0
Complexity:
214
Isotope Atom Count:
0
Defined Atom Stereocenter Count:
0
Undefined Atom Stereocenter Count:
0
Defined Bond Stereocenter Count:
0
Undefined Bond Stereocenter Count:
0
Covalently-Bonded Unit Count:
2
Compound Is Canonicalized:
Yes

Safety Information


GHS Pictogram:
Signal Word:
Warning
UN#:
-
Hazard Statements:
H302-H315-H319-H335
Precautionary Statements:
P280-P305+P351+P338
Class:
-
Packing Group:
-

NMR Spectrum


Other Analytical Data


Request for Quotation


Customer Feedback


Chemical Structure



Iproniazid phosphate is a versatile compound commonly used in chemical synthesis due to its pharmaceutical properties and reactivity. In the realm of organic chemistry, this substance is often employed as a key intermediate in the manufacturing of various drugs, particularly those aimed at treating mood disorders and psychiatric conditions.One notable application of Iproniazid phosphate in chemical synthesis is its role as a precursor in the production of monoamine oxidase inhibitors (MAOIs). MAOIs are a class of medications known for their ability to elevate levels of neurotransmitters in the brain, such as serotonin, norepinephrine, and dopamine. By inhibiting the activity of monoamine oxidase enzymes, these drugs can help alleviate symptoms of depression, anxiety, and other mental health disorders.In the synthesis of MAOIs, Iproniazid phosphate serves as a crucial building block that undergoes various chemical transformations to ultimately yield the desired therapeutic agents. Its structural features and functional groups enable chemists to introduce specific modifications and substitutions, allowing for the creation of diverse molecules with tailored pharmacological profiles.Furthermore, Iproniazid phosphate can also be utilized in the development of novel drug candidates through structure-activity relationship studies and lead optimization efforts. By leveraging its chemical properties and reactivity, researchers can explore different chemical modifications and analogs to improve drug efficacy, pharmacokinetics, and safety profiles.Overall, the application of Iproniazid phosphate in chemical synthesis underscores its importance in the pharmaceutical industry as a valuable tool for the creation of therapeutic agents targeting mental health disorders. Its versatility and utility make it a cornerstone in the development of innovative drug treatments, offering new perspectives and solutions for improving patient outcomes and well-being.